Previous studies have shown that excessive activation of the STAT3 signaling pathway is involved in proliferation, metastasis, angiogenesis, stemness, therapeutic resistance, and the immunosuppressive microenvironment in GBM [26–28]. This evidence concerns the gene STAT3 and glioblastoma.